XML 41 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
BUSINESS COMBINATION (Details 4) (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Dec. 31, 2012
Jun. 19, 2013
Business Combination, Acquisition Related Costs $ 5,658,460 $ 928,695  
Share Price     $ 1.22
Teva License Intangible Asset [Member]
     
Finite-Lived Intangible Asset, Useful Life 11 years    
BioSante Pharmaceuticals Inc [Member]
     
Business Acquisition, Percentage of Voting Interests Acquired     43.00%
ANIP Acquisition Company [Member]
     
Business Acquisition, Percentage of Voting Interests Acquired     57.00%